Research ArticleArticle
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal and Pierre Geborek
The Journal of Rheumatology January 2016, 43 (1) 81-87; DOI: https://doi.org/10.3899/jrheum.150744
Lars Erik Kristensen
From the Department of Rheumatology, and Musculoskeletal Statistics Unit, the Parker Institute, Copenhagen,
Denmark; Department of Rheumatology, Diakonhjemmet Hospital, Oslo,
Norway; Department of Rheumatology, Sahlgrenska University, Gothenburg; Department of Rheumatology, Lund University Hospital, Lund,
Sweden; Copenhagen University Hospital at Frederiksberg, Frederiksberg,
Denmark.
Elisabeth Lie
Lennart T.H. Jacobsson
Robin Christensen
Philip J. Mease
Henning Bliddal
REFERENCES
- 1.↵
- Ruddy S,
- Harris ED Jr,
- Sledge CB
- van der Linden S,
- van der Heijde D
- 2.↵
- Haglund E,
- Bremander AB,
- Petersson IF,
- Strömbeck B,
- Bergman S,
- Jacobsson LT,
- et al.
- 3.↵
- 4.↵
- Mease PJ,
- Antoni CE
- 5.↵
- 6.↵
- Antoni C,
- Kavanaugh A,
- Kirkham B,
- Tutuncu Z,
- Burmester GR,
- Schneider U,
- et al.
- 7.↵
- Mease PJ,
- Gladman DD,
- Ritchlin CT,
- Ruderman EM,
- Steinfeld SD,
- Choy EH,
- et al;
- Adalimumab Effectiveness in Psoriatic Arthritis Trial Study Group
- 8.↵
- Mease PJ,
- Fleischmann R,
- Deodhar AA,
- Wollenhaupt J,
- Khraishi M,
- Kielar D,
- et al.
- 9.↵
- Kavanaugh A,
- McInnes I,
- Mease P,
- Krueger GG,
- Gladman D,
- Gomez-Reino J,
- et al.
- 10.↵
- Kristensen LE,
- Gülfe A,
- Saxne T,
- Geborek P
- 11.↵
- Kristensen LE,
- Englund M,
- Neovius M,
- Askling J,
- Jacobsson LT,
- Petersson IF
- 12.↵
- Gossec L,
- Smolen JS,
- Gaujoux-Viala C,
- Ash Z,
- Marzo-Ortega H,
- van der Heijde D,
- et al;
- European League Against Rheumatism
- 13.↵
- Ritchlin CT,
- Kavanaugh A,
- Gladman DD,
- Mease PJ,
- Helliwell P,
- Boehncke WH,
- et al;
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
- 14.↵
- 15.↵
- Kavanaugh A,
- Mease PJ,
- Gomez-Reino JJ,
- Adebajo AO,
- Wollenhaupt J,
- Gladman DD,
- et al.
- 16.↵
- 17.↵
- Fagerli KM,
- Lie E,
- van der Heijde D,
- Heiberg MS,
- Kalstad S,
- Rødevand E,
- et al.
- 18.↵
- Glintborg B,
- Ostergaard M,
- Krogh NS,
- Andersen MD,
- Tarp U,
- Loft AG,
- et al.
- 19.↵
- Coates LC,
- Cawkwell LS,
- Ng NW,
- Bennett AN,
- Bryer DJ,
- Fraser AD,
- et al.
- 20.↵
- Conti F,
- Ceccarelli F,
- Marocchi E,
- Magrini L,
- Spinelli FR,
- Spadaro A,
- et al.
- 21.↵
- 22.↵
- 23.↵
- 24.↵
- Saad AA,
- Ashcroft DM,
- Watson KD,
- Hyrich KL,
- Noyce PR,
- Symmons DP;
- British Society for Rheumatology Biologics Register
- 25.↵
- 26.↵
- Geborek P,
- Crnkic M,
- Petersson IF,
- Saxne T;
- South Swedish Arthritis Treatment Group
- 27.↵
- 28.↵
- DAS-SCORE
- 29.↵
- van Riel PL,
- Fransen J,
- Scott DL
- 30.↵
- 31.↵
- van Gestel AM,
- Prevoo ML,
- van ‘t Hof MA,
- van Rijswijk MH,
- van de Putte LB,
- van Riel PL
- 32.↵
- Barra L,
- Pope JE,
- Payne M
- 33.↵
- 34.↵
- 35.↵
- Neovius M,
- Arkema EV,
- Olsson H,
- Eriksson JK,
- Kristensen LE,
- Simard JF,
- et al.
- 36.↵
- Chatzidionysiou K,
- Askling J,
- Eriksson J,
- Kristensen LE,
- van Vollenhoven R;
- ARTIS group
In this issue
The Journal of Rheumatology
Vol. 43, Issue 1
1 Jan 2016
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal, Pierre Geborek
The Journal of Rheumatology Jan 2016, 43 (1) 81-87; DOI: 10.3899/jrheum.150744
Effectiveness and Feasibility Associated with Switching to a Second or Third TNF Inhibitor in Patients with Psoriatic Arthritis: A Cohort Study from Southern Sweden
Lars Erik Kristensen, Elisabeth Lie, Lennart T.H. Jacobsson, Robin Christensen, Philip J. Mease, Henning Bliddal, Pierre Geborek
The Journal of Rheumatology Jan 2016, 43 (1) 81-87; DOI: 10.3899/jrheum.150744